Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Phase II dose-ranging trial of the early bactericidal activity of PA-824.

Diacon AH, Dawson R, du Bois J, Narunsky K, Venter A, Donald PR, van Niekerk C, Erondu N, Ginsberg AM, Becker P, Spigelman MK.

Antimicrob Agents Chemother. 2012 Jun;56(6):3027-31. doi: 10.1128/AAC.06125-11. Epub 2012 Mar 19.

2.

Present status of chemotherapy for tuberculosis.

Grosset JH.

Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S347-52. Review.

PMID:
2652251
3.

PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis.

Dawson R, Diacon A.

Expert Opin Investig Drugs. 2013 Jul;22(7):927-32. doi: 10.1517/13543784.2013.801958. Epub 2013 May 21. Review.

PMID:
23687915
4.

Antituberculosis agents.

Goldberger MJ.

Med Clin North Am. 1988 May;72(3):661-8. Review.

PMID:
3280912
5.

[Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].

Göpel B, Götte K.

Laryngorhinootologie. 2005 Aug;84(8):610-9; quiz 621-2. Review. German.

PMID:
16080064
6.
7.

The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy.

Goutelle S, Bourguignon L, Maire P, Jelliffe RW, Neely MN.

Curr Pharm Des. 2014;20(39):6191-206. Review.

PMID:
25190098
8.

Nitroimidazoles for the treatment of TB: past, present and future.

Mukherjee T, Boshoff H.

Future Med Chem. 2011 Sep;3(11):1427-54. doi: 10.4155/fmc.11.90. Review.

9.

The safety of antituberculosis medications during breastfeeding.

Tran JH, Montakantikul P.

J Hum Lact. 1998 Dec;14(4):337-40. Review.

PMID:
10205455
10.

Adverse effects of oral second-line antituberculosis drugs in children.

Schaaf HS, Thee S, van der Laan L, Hesseling AC, Garcia-Prats AJ.

Expert Opin Drug Saf. 2016 Oct;15(10):1369-81. doi: 10.1080/14740338.2016.1216544. Epub 2016 Aug 5. Review.

PMID:
27458876
11.

Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis.

Barry CE 3rd, Boshoff HI, Dowd CS.

Curr Pharm Des. 2004;10(26):3239-62. Review.

PMID:
15544513

Supplemental Content

Support Center